RespirTech

RespirTech

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

RespirTech operates as a specialized distributor and service provider in the respiratory and digital health sectors, focusing on chronic conditions like bronchiectasis, cystic fibrosis, and neuromuscular diseases. Its core business involves providing Philips-manufactured high-frequency chest wall oscillation (HFCWO) and mechanical insufflation-exsufflation devices, complemented by a high-touch service model featuring licensed respiratory therapists and nurses. Founded in 2004, the company has established a strong clinical support and reimbursement navigation framework, positioning itself as a key facilitator between large medical device manufacturers and patients requiring chronic respiratory therapy.

RespiratoryBronchiectasisCystic FibrosisNeuromuscular DiseasesCOPD

Technology Platform

Distribution and integrated service support platform for Philips airway clearance devices (High Frequency Chest Wall Oscillation and Mechanical Insufflation-Exsufflation), including clinical specialist support, patient training, and reimbursement navigation.

Funding History

2
Total raised:$20M
Series B$15M
Series A$5M

Opportunities

Growth is driven by increasing prevalence of chronic respiratory diseases, expansion of diagnosis for conditions like non-CF bronchiectasis, and the healthcare system's focus on value-based care that rewards therapies reducing hospitalizations.
Deepening integration with large systems like the VA presents a significant opportunity.

Risk Factors

High dependency on a single manufacturer (Philips) for all products exposes the business to supply chain and strategic decisions made externally.
Revenue is heavily reliant on insurance reimbursement, which is subject to policy changes and payment cuts.
Competitive pressure exists from other device manufacturers and alternative therapies.

Competitive Landscape

RespirTech competes in the airway clearance device market, which includes other manufacturers of HFCWO vests (e.g., Hillrom, International Biophysics) and mechanical cough assist devices. Its primary differentiation is not the hardware but its wrapped-around service model of clinical specialist support and reimbursement expertise, which is less common among pure DME distributors.